| Not yet recruiting | 3 | 20 | NA | Brentuximab vedotin, 89ZR-Brentuximab | University Medical Center Groningen, Takeda | Diffuse Large B-cell-lymphoma | 01/25 | 01/26 | | |
| Withdrawn | N/A | 20 | Europe | 89Zr-atezolizumab PET scans | University Medical Center Groningen, Amsterdam UMC, location VUmc, Stichting Hemato-Oncologie voor Volwassenen Nederland, Hoffmann-La Roche | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 05/22 | 05/22 | | |
LUPIAE, NCT04587388: Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry |
|
|
| Recruiting | N/A | 500 | Europe, RoW | | European Hematology Association - Lymphoma Group, Associazione Angela Serra per la ricerca sul cancro, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Follicular Lymphoma, Relapsed/Refractory Follicular Lymphoma | 05/23 | 05/26 | | |
